Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system

<p>Abstract</p> <p>The intestinal immune system and the epithelium are the first line of defense in the gut. Constantly exposed to microorganisms from the environment, the gut has complex defense mechanisms to prevent infections, as well as regulatory pathways to tolerate commensal...

Full description

Bibliographic Details
Main Authors: Marchès Olivier, MacDonald Thomas T, Vossenkämper Anna
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Journal of Inflammation
Subjects:
Online Access:http://www.journal-inflammation.com/content/8/1/11
id doaj-30ba0992983f4e4192e8f8dab3b85e49
record_format Article
spelling doaj-30ba0992983f4e4192e8f8dab3b85e492020-11-25T00:55:42ZengBMCJournal of Inflammation1476-92552011-05-01811110.1186/1476-9255-8-11Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune systemMarchès OlivierMacDonald Thomas TVossenkämper Anna<p>Abstract</p> <p>The intestinal immune system and the epithelium are the first line of defense in the gut. Constantly exposed to microorganisms from the environment, the gut has complex defense mechanisms to prevent infections, as well as regulatory pathways to tolerate commensal bacteria and food antigens. Intestinal pathogens have developed strategies to regulate intestinal immunity and inflammation in order to establish or prolong infection. The organisms that employ a type III secretion system use a molecular syringe to deliver effector proteins into the cytoplasm of host cells. These effectors target the host cell cytoskeleton, cell organelles and signaling pathways. This review addresses the multiple mechanisms by which the type III secretion system targets the intestinal immune response, with a special focus on pathogenic <it>E. coli</it>.</p> http://www.journal-inflammation.com/content/8/1/11gut-associated lymphoid tissuetype 3 secretion systemEPECShigella
collection DOAJ
language English
format Article
sources DOAJ
author Marchès Olivier
MacDonald Thomas T
Vossenkämper Anna
spellingShingle Marchès Olivier
MacDonald Thomas T
Vossenkämper Anna
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
Journal of Inflammation
gut-associated lymphoid tissue
type 3 secretion system
EPEC
Shigella
author_facet Marchès Olivier
MacDonald Thomas T
Vossenkämper Anna
author_sort Marchès Olivier
title Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
title_short Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
title_full Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
title_fullStr Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
title_full_unstemmed Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system
title_sort always one step ahead: how pathogenic bacteria use the type iii secretion system to manipulate the intestinal mucosal immune system
publisher BMC
series Journal of Inflammation
issn 1476-9255
publishDate 2011-05-01
description <p>Abstract</p> <p>The intestinal immune system and the epithelium are the first line of defense in the gut. Constantly exposed to microorganisms from the environment, the gut has complex defense mechanisms to prevent infections, as well as regulatory pathways to tolerate commensal bacteria and food antigens. Intestinal pathogens have developed strategies to regulate intestinal immunity and inflammation in order to establish or prolong infection. The organisms that employ a type III secretion system use a molecular syringe to deliver effector proteins into the cytoplasm of host cells. These effectors target the host cell cytoskeleton, cell organelles and signaling pathways. This review addresses the multiple mechanisms by which the type III secretion system targets the intestinal immune response, with a special focus on pathogenic <it>E. coli</it>.</p>
topic gut-associated lymphoid tissue
type 3 secretion system
EPEC
Shigella
url http://www.journal-inflammation.com/content/8/1/11
work_keys_str_mv AT marchesolivier alwaysonestepaheadhowpathogenicbacteriausethetypeiiisecretionsystemtomanipulatetheintestinalmucosalimmunesystem
AT macdonaldthomast alwaysonestepaheadhowpathogenicbacteriausethetypeiiisecretionsystemtomanipulatetheintestinalmucosalimmunesystem
AT vossenkamperanna alwaysonestepaheadhowpathogenicbacteriausethetypeiiisecretionsystemtomanipulatetheintestinalmucosalimmunesystem
_version_ 1725229803263492096